Does liver ischemic preconditioning in brain death donors induce kidney preconditioning? a retrospective analysis

Transplantation

Volumn 97, Issue 3, 2014, Pages 337-343

  Desai, Kunj K ^a   Mora Esteves, Cesar ^a   Holland, Bart K ^a   Dikdan, George ^a   Fisher, Adrian ^a   Wilson, Dorian J ^a   Koneru, Baburao ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Delayed graft function; Donors after brain death; Ischemic preconditioning; Kidney transplantation; Remote preconditioning

Indexed keywords

ADULT; BRAIN DEATH; DELAYED GRAFT FUNCTION; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT SURVIVAL; HUMANS; ISCHEMIC PRECONDITIONING; KIDNEY TRANSPLANTATION; LENGTH OF STAY; LIVER; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; ORGAN PRESERVATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGISTRIES; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; TIME FACTORS; TISSUE AND ORGAN HARVESTING; TISSUE DONORS; TREATMENT OUTCOME;

EID: 84894097219     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000436926.30897.56     Document Type: Article

References (46)

1. Ojo AO, Wolfe RA, Held PJ, et al. Delayed graft function: risk factors and implications for renal allograft survival. Transplantation 1997; 63: 968.
2. Irish WD, McCollum DA, Tesi RJ, et al. Nomogram for predicting the likelihood of delayed graft function in adult cadaveric renal transplant recipients. J Am Soc Nephrol 2003; 14: 2967.
3. Yarlagadda SG, Coca SG, Formica RN Jr, et al. Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis. Nephrol Dial Transplant 2009; 24: 1039.
4. Rodrigo E, Fernandez-Fresnedo G, Ruiz JC, et al. Similar impact of slow and delayed graft function on renal allograft outcome and function. Transplant Proc 2005; 37: 1431.
5. Matas AJ, Gillingham KJ, Elick BA, et al. Risk factors for prolonged hospitalization after kidney transplants. Clin Transplant 1997; 11: 259.
6. Salahudeen AK, May W. Reduction in cold ischemia time of renal allografts in the United States over the last decade. Transplant Proc 2008; 40: 1285.
7. Schnuelle P, Gottmann U, Hoeger S, et al. Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial. JAMA 2009; 302: 1067.
8. Huland H, Bause HW, Clausen C, et al. The influence of an angio-tensin II antagonist, saralasin, given before donor nephrectomy, on kidney function after transplantation. A controlled prospective study. Transplantation 1983; 36: 139.
9. Wight JP, Chilcott JB, Holmes MW, et al. Pulsatile machine perfusion vs. cold storage of kidneys for transplantation: a rapid and systematic review. Clin Transplant 2003; 17: 293.
10. Moers C, Smits JM, Maathuis MH, et al. Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med 2009; 360: 7.
11. Goggins WC, Pascual MA, Powelson JA, et al. A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients. Transplantation 2003; 76: 798.
12. Shilliday IR, Sherif M. Calcium channel blockers for preventing acute tubular necrosis in kidney transplant recipients. Cochrane Database Syst Rev 2007; CD003421.
13. Shoskes D, Lapierre C, Cruz-Correa M, et al. Beneficial effects of the bioflavonoids curcumin and quercetin on early function in cadaveric renal transplantation: a randomized placebo controlled trial. Transplantation 2005; 80: 1556.
14. Kainz A, Wilflingseder J, Mitterbauer C, et al. Steroid pretreatment of organ donors to prevent postischemic renal allograft failure: a randomized, controlled trial. Ann Intern Med 2010; 153: 222.
15. Pollak R, Andrisevic JH, Maddux MS, et al. A randomized double-blind trial of the use of human recombinant superoxide dismutase in renal transplantation. Transplantation 1993; 55: 57.
16. Noel C, Hazzan M, Coppin MC, et al. A randomized controlled trial of pentoxifylline for the prevention of delayed graft function in cadaveric kidney graft. Clin Transplant 1997; 11: 169.
17. Hladunewich MA, Corrigan G, Derby GC, et al. A randomized, placebo-controlled trial of IGF-1 for delayed graft function: a human model to study postischemic ARF. Kidney Int 2003; 64: 593.
18. Acker CG, Flick R, Shapiro R, et al. Thyroid hormone in the treatment of post-transplant acute tubular necrosis (ATN). Am J Transplant 2002; 2: 57.
19. Sands JM, Neylan JF, Olson RA, et al. Atrial natriuretic factor does not improve the outcome of cadaveric renal transplantation. J Am Soc Nephrol 1991; 1: 1081.
20. Salmela K, Wramner L, Ekberg H, et al. A randomized multicenter trial of the anti-ICAM-1 monoclonal antibody (enlimomab) for the prevention of acute rejection and delayed onset of graft function in cadaveric renal transplantation: a report of the European Anti-ICAM-1 Renal Transplant Study Group. Transplantation 1999; 67: 729.
21. Lee HT, Emala CW. Protective effects of renal ischemic preconditioning and adenosine pretreatment: role of A(1) and A(3) receptors. Am J Physiol Renal Physiol 2000; 278: F380.
22. Torras J, Herrero-Fresneda I, Lloberas N, et al. Promising effects of ischemic preconditioning in renal transplantation. Kidney Int 2002; 61: 2218.
23. Azoulay D, Del Gaudio M, Andreani P, et al. Effects of 10 minutes of ischemic preconditioning of the cadaveric liver on the graft's preservation and function: the ying and the yang. Ann Surg 2005; 242: 133.
24. Koneru B, Shareef A, Dikdan G, et al. The ischemic preconditioning paradox in deceased donor liver transplantation-evidence from a prospective randomized single blind clinical trial. Am J Transplant 2007; 7: 2788.
25. Amador A, Grande L, Marti J, et al. Ischemic pre-conditioning in deceased donor liver transplantation: a prospective randomized clinical trial. Am J Transplant 2007; 7: 2180.
26. Koneru B, Fisher A, He Y, et al. Ischemic preconditioning in deceased donor liver transplantation: a prospective randomized clinical trial of safety and efficacy. Liver Transpl 2005; 11: 196.
27. Przyklenk K, Bauer B, Ovize M, et al. Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 1993; 87: 893.
28. Tapuria N, Kumar Y, Habib MM, et al. Remote ischemic preconditioning: a novel protective method from ischemia reperfusion injuryVa review. J Surg Res 2008; 150: 304.
29. Ates E, Genc E, Erkasap N, et al. Renal protection by brief liver ischemia in rats. Transplantation 2002; 74: 1247.
30. Nikeghbalian S, Mansoorian MR, Hosseini SM, et al. Reduction of the severity of ischemia reperfusion-induced pancreatitis by ische-mic pre-conditioning of the liver. Saudi J Kidney Dis Transplant 2009; 20: 1010.
31. Ali ZA, Callaghan CJ, Lim E, et al. Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic an-eurysm repair: a randomized controlled trial. Circulation 2007; 116: I98.
32. Venugopal V, Laing CM, Ludman A, et al. Effect of remote ischemic preconditioning on acute kidney injury in nondiabetic patients undergoing coronary artery bypass graft surgery: a secondary analysis of 2 small randomized trials. Am J Kidney Dis 2010; 56: 1043.
33. Cescon M, Grazi GL, Grassi A, et al. Effect of ischemic preconditioning in whole liver transplantation from deceased donors. A pilot study. Liver Transplant 2006; 12: 628.
34. Jassem W, Fuggle SV, Cerundolo L, et al. Ischemic preconditioning of cadaver donor livers protects allografts following transplantation. Transplantation 2006; 81: 169.
35. AT P channel-dependent mechanism. Transplantation 2005; 79: 1691.
36. Chiari P, Piriou V, Hadour G, et al. Preservation of ischemia and isoflurane-induced preconditioning after brain death in rabbit hearts. Am J Physiol Heart Circ Physiol 2002; 283: H1769.
37. Alreja G, Bugano D, Lotfi A. Effect of remote ischemic preconditioning on myocardial and renal injury: meta-analysis of randomized controlled trials. J Invasive Cardiol 2012; 24: 42.
38. Peart JN, Gross ER, Gross GJ. Opioid-induced preconditioning: recent advances and future perspectives. Vasc Pharmacol 2005; 42: 211.
39. Murphy GS, Szokol JW, Marymont JH, et al. Opioids and cardio-protection: the impact of morphine and fentanyl on recovery of ventricular function after cardiopulmonary bypass. J Cardiothor Vasc Anesth 2006; 20: 493.
40. Wong GT, Huang Z, Ji S, et al. Remifentanil reduces the release of biochemical markers of myocardial damage after coronary artery bypass surgery: a randomized trial. J Cardiothor Vasc Anesth 2010; 24: 790.
41. Beck-Schimmer B, Breitenstein S, Urech S, et al. A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic. Ann Surg 2008; 248: 909.
42. Hanto DW, Maki T, Yoon MH, et al. Intraoperative administration of inhaled carbon monoxide reduces delayed graft function in kidney allografts in swine. Am J Transplant 2010; 10: 2421.
43. Donckier V, Loi P, Closset J, et al. Preconditioning of donors with interleukin-10 reduces hepatic ischemia-reperfusion injury after liver transplantation in pigs. Transplantation 2003; 75: 902.
44. Benck U, Hoeger S, Brinkkoetter PT, et al. Effects of donor pre-treatment with dopamine on survival after heart transplantation: a cohort study of heart transplant recipients nested in a randomized controlled multicenter trial. J Am Coll Cardiol 2011; 58: 1768.
45. Chen Y, Zheng H, Wang X, et al. Remote ischemic preconditioning fails to improve early renal function of patients undergoing living-donor renal transplantation: a randomized controlled trial. Transplantation 2013; 95: e4.
46. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461.